Risk factors of short-term colectomy following Janus kinase inhibitor therapy in acute severe ulcerative colitis: a systematic review and meta-analysis of individual-level data from real-world studies
Crohn’s & Colitis 360 · 05.10.2026 · 8 (4)
DOI: 10.1093/crocol/otag120 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Crohn’s & Colitis 360, online erschienen am 23.10.2026. Verfasst von Yuntao Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Emerging evidence supports the use of Janus kinase inhibitors (JAKi) in acute severe ulcerative colitis (ASUC). However, risk factors associated with non-response and the need for short-term colectomy in ASUC patients treated with JAKi remain poorly understood.
Methods
We conducted a systematic review and individual-level data meta-analysis of real-world studies evaluating tofacitinib or upadacitinib for the treatment of ASUC. The primary and secondary outcomes were colectomy within 30 days and 12 weeks, respectively. Generalized linear mixed-effects models were used for univariable and multivariable analyses to estimate odds ratios (ORs). A stratified Cox proportional hazards model was used to assess colectomy-free survival.
Results
Twenty-three studies with 145 patients were included (69.0% treated with tofacitinib, 31.0% with upadacitinib). The overall colectomy rate was 13.1% within 30 days and 20.5% within 12 weeks. In univariable analyses, prior exposure to anti-tumor necrosis factor (TNF) therapy before ASUC hospitalization was statistically significantly associated with lower odds of colectomy within 30 days (OR 0.44, P = .006) and 12 weeks (OR 0.51, P = .008). Prior anti-TNF exposure remained significantly associated with lower odds of colectomy in multiple multivariable analyses. No other clinical or laboratory variables were significantly associated with primary/secondary outcomes.
Conclusions
Prior anti-TNF exposure before hospitalization is associated with lower short-term colectomy rates in ASUC patients treated with JAKi. Our findings highlight the need for future studies to optimize the position of JAKi in the ASUC management algorithm and to identify novel predictive biomarkers to advance precision medicine strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hospital Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.
- Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.
- Divison of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
ORCID-Profile: David I Fudman, Shrinivas Bishu, Jeffrey A Berinstein, Ezra Burstein, Moheb Boktor, Jianyi Yin
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Zou, Y., Fudman, D. I., Bishu, S., Berinstein, J. A., Burstein, E., Boktor, M., & Yin, J. (2026). Risk factors of short-term colectomy following Janus kinase inhibitor therapy in acute severe ulcerative colitis: a systematic review and meta-analysis of individual-level data from real-world studies. Crohn’s & Colitis 360, 8(4). https://doi.org/10.1093/crocol/otag120
Vancouver
Zou Y, Fudman DI, Bishu S, Berinstein JA, Burstein E, Boktor M, et al. Risk factors of short-term colectomy following Janus kinase inhibitor therapy in acute severe ulcerative colitis: a systematic review and meta-analysis of individual-level data from real-world studies. Crohn’s & Colitis 360. 2026;8(4). doi:10.1093/crocol/otag120
BibTeX
@article{Zou2026,
author = {Zou, Yuntao and Fudman, David I and Bishu, Shrinivas and Berinstein, Jeffrey A and Burstein, Ezra and Boktor, Moheb and Yin, Jianyi},
title = {Risk factors of short-term colectomy following Janus kinase inhibitor therapy in acute severe ulcerative colitis: a systematic review and meta-analysis of individual-level data from real-world studies},
journal = {Crohn’s & Colitis 360},
year = {2026},
volume = {8},
number = {4},
doi = {10.1093/crocol/otag120}
}
EUVIMED